Singapore has emerged as a significant player S in the global deep tech landscape. Over the past decade, the government has committed more than S$19 billion to advance research and development in deep tech, according to the Sparkmate report.
There are several initiatives aimed to strengthen the startup landscape in this sector. One key initiative driving Singapore's deep tech agenda is the Singapore Deep-Tech Alliance (SDTA), which facilitates partnerships and provides avenues for companies to create new startups, bring existing ones to market, find solutions to challenges, and access protected technologies. This initiative enhances collaboration and accelerates the growth of deep tech ventures within Singapore's ecosystem.
In addition, Singapore launched A*StartCentral (A*SC) in 2016, a first-of-its-kind open innovation platform by the Agency for Science Technology and Research (A*STAR). It aims to incubate and accelerate the growth of deep tech startups, and serves to bolster the startup ecosystem, including areas such as medtech and life sciences. Now it has over 150 deep tech startups.
"A*StartCentral (A*SC), a key player in Singapore's deep tech ecosystem, empowers earlystage startups in their entrepreneurial journey. By providing guidance and support, A*StartCentral enables startups to expand beyond Singapore and tap into global markets, fostering innovation and entrepreneurship on an international scale," said Emily Liew, Assistant Chief Executive Officer, Innovation & Enterprise Services, Enterprise Singapore.
A*SC builds upon the foundation of an open innovation community to foster crosspollination and interaction amongst researchers, corporates, startups, investors and entrepreneurs across diverse disciplines. A*SC will continue to inspire, innovate with, and empower researcherentrepreneurs in building successful, deep technology enabled ventures.
Esta historia es de la edición March 2024 de BioSpectrum Asia.
Comience su prueba gratuita de Magzter GOLD de 7 días para acceder a miles de historias premium seleccionadas y a más de 9,000 revistas y periódicos.
Ya eres suscriptor ? Conectar
Esta historia es de la edición March 2024 de BioSpectrum Asia.
Comience su prueba gratuita de Magzter GOLD de 7 días para acceder a miles de historias premium seleccionadas y a más de 9,000 revistas y periódicos.
Ya eres suscriptor? Conectar
Australia develops AI sperm checker to enhance IVF success
Engineers in Australia have developed an artificial intelligence (AI) technology that accurately assesses the quality of live sperm in seconds, removing the need for invasive procedures that compromise sperm viability in vitro fertilisation (IVF) treatments.
Singapore discovers new fungus type, a possible global public health threat
Researchers from the Singapore General Hospital (SGH), A*STAR’s Genome Institute of Singapore (GIS) and Yong Loo Lin School of Medicine at National University of Singapore (NUS Medicine) have discovered a new clade (or type) of Candida auris, bringing the number of clades known globally to a total of six.
Singapore strengthens focus on computational biology
Singapore's National Quantum Office (NQO), Agency for Science, Technology and Research (A*STAR), National University of Singapore (NUS), National Supercomputing Centre (NSCC) and Quantinuum have signed a Memorandum of Understanding (MoU), enabling access to Quantinuum's advanced quantum computer, and to explore and collaborate on quantum computing use cases, focusing on computational biology.
Global scientists explore innovative tech to rapidly make new vaccine antigens
Researchers in the US are pursuing pioneering technology that may be able to rapidly create safe and effective vaccines against deadly epidemic and pandemic diseases that are more stable and less expensive than current vaccines.
Korea develops micro-structured artificial lung model using bioprinting technology
A team of Korean researchers has made a breakthrough that will greatly enhance the efficiency of respiratory disease research, garnering attention.
Philips names Ling Liu as Chief Region Leader of Greater China
Royal Philips, a global leader in health technology, has announced the appointment of Ling Liu as the Chief Region Leader of Philips Greater China.
PW Skills launches School of Healthcare to solve India's critical shortage of medical professionals
PW Skills, the upskilling vertical of Physics Wallah (PW) has announced the launch of School of Healthcare across five cities in India, namely, Noida, Indore, Lucknow, Patna and Delhi.
Australian biotech incubator Proto Axiom announces $20 M Series B first close
Proto Axiom, the Australian biomedical technology incubator, has announced a $20 million first close of its targeted $30 million Series B, to bolster Australia's biotechnology sector through increased intellectual property (IP) retention.
Biogen, Beckman Coulter and Fujirebio to develop new tests for tau pathology
Biogen Inc., Beckman Coulter, Inc. (both based in the US) and Japan-based Fujirebio have announced a collaboration to potentially identify and develop blood-based biomarkers for tau pathology in the brain and to potentially clinically advance and potentially commercialise new tests for tau pathology in Alzheimer’s disease (AD).
Pfizer upgrades pharma production plant in Melbourne
Australia is stepping up to the global fight against antimicrobial resistance, as Pfizer Australia announces a major upgrade to its manufacturing facility in Melbourne, Victoria.